Management | Number of cases | Percentage |
Surgical | 295 | 93.9% |
Hysterectomy | 19 | 6% |
Post-surgery Adjuvant methotrexate | 9 | 2.9% |
Primary Methotrexate followed by surgery | 10 | 3.2% |
USG guided percutaneous microwave ablation |
1
|
0.3%
|
Placental removal | ||
Complete | 264 | 84% |
Partial | 27 | 8.6% |
Left in situ | 16 | 5.1% |
NA (not available) | 7 | 2.3% |
Maternal morbidity/mortality | ||
Transfusions | 74 | 23.6% |
Death | 15 | 4.8% |
Neonatal morbidity/mortality | ||
<20 weeks gestation | 241 | 76.8% |
Live born (including NND) | 27 | 8.6% |
Fetal demise (IUFD/stillborn) | 46 | 14.6% |
NND | 6 | 1.9% |